Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-005338-23Phase 2Active
Phase 2, single-arm trial of propranolol in panic disorder, sponsored by University of Amsterdam. Primary endpoint: Absence of panic disorder diagnosis and symptom reduction. Started Jul 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-005338-23.